Phage on tap-a quick and efficient protocol for the preparation of bacteriophage laboratory stocks

PeerJ

Volumn 2016, Issue 7, 2016, Pages

  Bonilla, Natasha ^a   Rojas, Maria Isabel ^a   Cruz, Giuliano Netto Flores ^a   Hung, Shr Hau ^a   Rohwer, Forest ^a   Barr, Jeremy J ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Bacteriophage; Cesium chloride; Dialysis; Endotoxin; Phage bank; Speed vacuum; Top agar; Ultrafiltration

Indexed keywords

CESIUM CHLORIDE; CHLOROFORM; ENDOTOXIN;

ARTICLE; BACTERIOPHAGE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); DIALYSIS; ENTEROBACTERIA PHAGE T4; MEDICAL PROCEDURES; NONHUMAN; PHAGE ON TAP; PLAQUE ASSAY; PURIFICATION; ULTRAFILTRATION; VACUUM; VELOCITY;

EID: 84981505102     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.2261     Document Type: Article

References (33)

1. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. 2011. Phage treatment of human infections. Bacteriophage 1(2):66-85 DOI 10.4161/bact.1.2.15845.
2. Ackermann H-W, Tremblay D, Moineau S. 2004. Long-term bacteriophage preservation. WFCC Newsletter 38:35-40.
3. Adams MH. 1959. Bacteriophages. New York: Interscience.
4. Alexander C, Rietschel ET. 2001. Invited review: bacterial lipopolysaccharides and innate immunity. Journal of Endotoxin Research 7(3):167-202 DOI 10.1177/09680519010070030101.
5. Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, Stotland A, Wolkowicz R, Cutting AS, Doran KS, Salamon P, Youle M, Rohwer F. 2013. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proceedings of the National Academy of Sciences of the United States of America 110(26):10771-10776 DOI 10.1073/pnas.1305923110.
6. Barr JJ, Auro R, Sam-Soon N, Kassegne S, Peters G, Bonilla N, Hatay M, Mourtada S, Bailey B, Youle M, Felts B, Baljon A, Nulton J, Salamon P, Rohwer F. 2015. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. Proceedings of the National Academy of Sciences of the United States of America 112(44):13675-13680 DOI 10.1073/pnas.1508355112.
7. Boratyński J, Syper D, Weber-Dabrowska B, qusiak-Szelachowska M, Poźniak G, Górski A. 2004. Preparation of endotoxin-free bacteriophages. Cellular & Molecular Biology Letters 9(2):253-259.
8. Bourdin G, Schmitt B, Marvin Guy L, Germond J-E, Zuber S, Michot L, Reuteler G, Brüssow H. 2014. Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale. Applied and Environmental Microbiology 80(4):1469-1476 DOI 10.1128/AEM.03357-13.
9. Branston SD, Wright J, Keshavarz-Moore E. 2015. A non-chromatographic method for the removal of endotoxins from bacteriophages. Biotechnology and Bioengineering 112(8): 1714-1719 DOI 10.1002/bit.25571.
10. Bruttin A, Brüssow H. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrobial Agents and Chemotherapy 49(7):2874-2878 DOI 10.1128/AAC.49.7.2874-2878.2005.
11. Carlson K. 2005. Appendix: working with bacteriophages: common techniques and methodological approaches. In: Kutter E, Sulakvelidze A, eds. Bacteriophages: Biology and Applications. Vol. 1. Boca Raton: CRC Press, 439-490.
12. Chan BK, Abedon ST, Loc-Carrillo C. 2013. Phage cocktails and the future of phage therapy. Future Microbiology 8(6):769-783 DOI 10.2217/fmb.13.47.
13. Clark WA. 1962. Comparison of several methods for preserving bacteriophages. Applied Environmental Microbiology 10(5):466-471.
14. Clark WA, Geary D. 1973. Preservation of bacteriophages by freezing and freeze-drying. Cryobiology 10(5):351-360 DOI 10.1016/0011-2240(73)90057-6.
15. Clark WA, Klein A. 1966. The stability of bacteriophages in long term storage at liquid nitrogen temperatures. Cryobiology 3(2):68-75 DOI 10.1016/S0011-2240(66)80002-0.
16. Erickson HP. 2009. Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biological Procedures Online 11(1):32-51 DOI 10.1007/s12575-009-9008-x.
17. Gorbet MB, Sefton MV. 2005. Endotoxin: the uninvited guest. Biomaterials 26(34):6811-6817 DOI 10.1016/j.biomaterials.2005.04.063.
18. Jończyk E, K1ak M, Miedzybrodzki R, Górski A. 2011. The influence of external factors on bacteriophages-review. Folia Microbiologica 56(3):191-200 DOI 10.1007/s12223-011-0039-8.
19. Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Pessoa A Jr. 2007. Methods of endotoxin removal from biological preparations: a review. Journal of Pharmacy & Pharaceutical Sciences 10(3):388-404.
20. Merabishvili M, Pirnay J-P, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G, Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4(3):e4944 DOI 10.1371/journal.pone.0004944.
21. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S. 1996. Long-circulating bacteriophage as antibacterial agents. Proceedings of the National Academy of Sciences of the United States of America 93(8):3188-3192 DOI 10.1073/pnas.93.8.3188.
22. Merril CR, Scholl D, Adhya SL. 2003. The prospect for bacteriophage therapy in Western medicine. Nature Reviews Drug Discovery 2(6):489-497 DOI 10.1038/nrd1111.
23. Morrison DC, Leive L. 1975. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. Journal of Biological Chemistry 250:2911-2919.
24. Morrison DC, Ulevitch RJ. 1978. The effects of bacterial endotoxins on host mediation systems. A review. American Journal of Pathology 93(2):526-618.
25. Ośliz1o A, Miernikiewicz P, Piotrowicz A, Owczarek B, Kopciuch A, Figura G, Dabrowska K. 2011. Purification of phage display-modified bacteriophage T4 by affinity chromatography. BMC Biotechnology 11(1):59 DOI 10.1186/1472-6750-11-59.
26. Pabst MJ, Pabst KM, Handsman DB, Beranova-Giorgianni S, Giorgianni F. 2008. Proteome of monocyte priming by lipopolysaccharide, including changes in interleukin-1beta and leukocyte elastase inhibitor. Proteome Science 6(1):13 DOI 10.1186/1477-5956-6-13.
27. Raetz CRH, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid a modification systems in gram-negative bacteria. Annual Review of Biochemistry 76(1):295-329 DOI 10.1146/annurev.biochem.76.010307.145803.
28. Rietschel E, Kirikae T, Schade F, Mamat U, Schmidt G, Loppnow H, Ulmer A, Zahringer U, Seydel U, Di Padova F. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB Journal 8(2):217-225.
29. Seeley ND, Primrose SB. 1982. A review: the isolation of bacteriophages from the environment. Journal of Applied Bacteriology 53(1):1-17 DOI 10.1111/j.1365-2672.1982.tb04729.x.
30. Suttle CA, Chan AM, Cottrell MT. 1991. Use of ultrafiltration to isolate viruses from seawater which are pathogens of marine Phytoplankton. Applied Environmental Microbiology 57(3):721-726.
31. Szermer-Olearnik B, Boratyński J. 2015. Removal of endotoxins from bacteriophage preparations by extraction with organic solvents. PLoS ONE 10(3):e122672 DOI 10.1371/journal.pone.0122672.
32. Wommack KE, Hill RT, Muller TA, Colwell RR. 1996. Effects of sunlight on bacteriophage viability and structure. Applied and Environmental Microbiology 62(4):1336-1341.
33. Yamamoto KR, Alberts BM, Benzinger R, Lawhorne L, Treiber G. 1970. Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology 40(3):734-744 DOI 10.1016/0042-6822(70)90218-7.